Puhlmann Markus 4
4 · Perspective Therapeutics, Inc. · Filed Jan 26, 2024
Insider Transaction Report
Form 4
Puhlmann Markus
Chief Medical Officer
Transactions
- Purchase
Common Stock
2024-01-24$0.50/sh+280,000$139,888→ 1,375,425 total
Footnotes (1)
- [F1]This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4871 to $0.5000, inclusive. The reporting person undertakes to provide to Perspective Therapeutics, Inc., any security holder of Perspective Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.